β3-receptor agonists for overactive bladder--new frontier or more of the same?
about
Urinary considerations for adult patients with spinal dysraphism.Combination treatments for overactive bladder refractory to first-line pharmacotherapy: do they meet expectations?Combination therapy with β3 -adrenoceptor agonists and muscarinic acetylcholine receptor antagonists: Efficacy in rats with bladder overactivity.
P2860
β3-receptor agonists for overactive bladder--new frontier or more of the same?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
β3-receptor agonists for overactive bladder--new frontier or more of the same?
@en
type
label
β3-receptor agonists for overactive bladder--new frontier or more of the same?
@en
prefLabel
β3-receptor agonists for overactive bladder--new frontier or more of the same?
@en
P2860
P1476
β3-receptor agonists for overactive bladder--new frontier or more of the same?
@en
P2093
Karl-Erik Andersson
P2860
P2888
P304
P356
10.1007/S11934-013-0335-8
P577
2013-10-01T00:00:00Z
P6179
1018528065